ArticleTherapeutic advances in gastroenterology2022

Expression of PD-L1 as a predictive marker of sensitivity to immune checkpoint inhibitors in patients with advanced biliary tract cancer.

Hongsik Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.